Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-24

Clinical Trial Update: Treatment of Behavioral Symptoms in Alzheimer's Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating treatment of behavioral symptoms in Alzheimer's disease has completed, including psychosis and agitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Alzheimer's Disease, Psychosis | Phase 4 | Status: COMPLETED